- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03912701
Early Warning Systems, Risk of Early Clinical Deterioration
July 16, 2019 updated by: ILKE KUPELI, Erzincan University
If Early Warning Systems Were Used, Could the Risk of Early Clinical Deterioration be Predicted and Re-admission to Intensive Care Could be Prevented
Primary purpose of the study was to evaluate the relationship between "NEWS" and "VIEWS" scores of patients who were screened retrospectively, early clinical deterioration, return to intensive care and morbidity / mortality.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Erzincan, Turkey, 24100
- Recruiting
- Erzincan University
-
Contact:
- ufuk kuyrukluyıldız
- Phone Number: +904462122222
- Email: drufuk2001@gmail.com
-
Principal Investigator:
- İLKE KÜPELİ
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients over the age of 18 and discharged and admitted to intensive care in the first 24 hours
Description
Inclusion Criteria:
- over 18 years
- patients who were taken back to the intensive care unit in the first 24 hours
Exclusion Criteria:
- under 18 years old,
- patients undergoing postoperative intensive care,
- pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients who were taken back to intensive care unit due to early clinical deterioration
Time Frame: six month
|
Number of patients who were taken back to intensive care unit due to early clinical deterioration
|
six month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kaben A, Correa F, Reinhart K, Settmacher U, Gummert J, Kalff R, Sakr Y. Readmission to a surgical intensive care unit: incidence, outcome and risk factors. Crit Care. 2008;12(5):R123. doi: 10.1186/cc7023. Epub 2008 Oct 6.
- Prytherch DR, Smith GB, Schmidt PE, Featherstone PI. ViEWS--Towards a national early warning score for detecting adult inpatient deterioration. Resuscitation. 2010 Aug;81(8):932-7. doi: 10.1016/j.resuscitation.2010.04.014.
- McGinley A, Pearse RM. A national early warning score for acutely ill patients. BMJ. 2012 Aug 8;345:e5310. doi: 10.1136/bmj.e5310. No abstract available.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 1, 2019
Primary Completion (Anticipated)
November 1, 2019
Study Completion (Anticipated)
November 15, 2019
Study Registration Dates
First Submitted
April 9, 2019
First Submitted That Met QC Criteria
April 10, 2019
First Posted (Actual)
April 11, 2019
Study Record Updates
Last Update Posted (Actual)
July 17, 2019
Last Update Submitted That Met QC Criteria
July 16, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EBYU 3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.